Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)
Completed
Nycomed
2006-12-01
The objectives of the study are to obtain knowledge about the safety in use, the patients'
general impression of the treatment and the pattern of use of ZyComb® in an over-the-counter
(OTC) setting.
In the Lung Health Study I, to determine the effects of Special Care, compared to Usual Care,
on rate of decline in pulmonary function in a group of cigarette smokers identified as having
mild abnormalities in pulmonary function.
In the Lung Health Study III, to determine the long-term effects of smoking cessation and
continued smoking, on cardiopulmonary morbidity, mortality, and the rate of decline in the
one second forced expiratory volume (FEV1) in men and women with early chronic obstructive
lung disease who have been followed prospectively for 12 to 15 years.
This study will establish a network of interactive asthma clinical research groups to
evaluate current therapies, new therapies, and management strategies for adult asthma.
This study will establish a network of interactive asthma clinical research groups to
evaluate current therapies, new therapies, and management strategies for adult asthma.
Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)
Completed
Asthma Clinical Research Network
Phase 3
2004-12-01
The purpose of this trial is to determine whether regularly scheduled use of an inhaled
long-acting beta agonist (salmeterol) in the setting of concomitant use of inhaled
corticosteroids (beclomethasone hydroflouroalkane (HFA) inhaler) will have a detrimental
effect on asthma control in people who bear the B16-Arg/Arg genotype of the beta-2 adrenergic
receptor gene, as compared to people with asthma of similar severity who bear the B16-Gly/Gly
genotype.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
